Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists

This systematic review and meta-analysis quantifies the heterogeneity of treatment effects of glucagon-like peptide-1 receptor agonists, including semaglutide, liraglutide, exenatide, lixisenatide, and dulaglutide.

from JAMA Internal Medicine Online First https://ift.tt/T24XD9A

Comments

Popular posts from this blog

Skilled Nursing Facilities and Sufficient Bed Capacity